Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

FFA's causes may include environmental triggers and genetic factors.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Hair transplant destroyed by lichen planopilaris.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Hair transplantation might work for some people with frontal fibrosing alopecia, but more research is needed.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Trichoscopy effectively diagnoses eyebrow loss, distinguishing between alopecia areata and frontal fibrosing alopecia.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

Regular use of sunscreen may be linked to frontal fibrosing alopecia.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.